Please assess the completion status of the following clinical trial:

Trial Title: Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Patients are eligible to be included in the study if they meet all of the following criteria:~* are ≥ 18 years of age~* have been diagnosed with STEMI or NSTEMI during the index hospitalization~* be treated with a P2Y12 receptor inhibitor at the time of enrollment~* have U.S. based health insurance coverage with prescription drug benefit~* have been fully informed and are able to provide written consent for longitudinal follow-up~Exclusion Criteria:~Patients are excluded if they meet any of the following criteria:~* have a history of prior intracranial hemorrhage~* have any contraindications to P2Y12 receptor inhibitor therapy at discharge~* involvement in another research study that specifies the type and duration of P2Y12 receptor inhibitor use within the next 12 months.~* have a life expectancy of less than one year~* have plans to move outside the US in the next year

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 130 Years
- Healthy Volunteers: f

Study Arms:
- Copayment Intervention Arm (Type: EXPERIMENTAL): Sites in the intervention arm will provide patients with a study voucher card to offset any patient copayments or medication card for the filling of any prescriptions of clopidogrel or ticagrelor.
- Usual Care Arm (Type: NO_INTERVENTION): For hospitals randomized to the control arm, all patients receive usual care and no study intervention is performed.

Based on this trial design, predict the completion outcome and termination type (if applicable).